Related Experiment Videos
Facial nerve in recurrent benign pleomorphic adenoma
Summary
Parotid gland tumor treatments have improved, reducing recurrence rates by abandoning enucleation for lateral lobectomy. Management strategies now range from reexcision to complex parotidectomy with nerve preservation or grafting.
Area of Science:
- Oncology
- Surgical Oncology
- Otolaryngology
Background:
- Benign and malignant parotid gland tumors present significant clinical challenges.
- Tumor recurrence, particularly for benign mixed tumors, remains a concern despite treatment advancements.
Purpose of the Study:
- To review the management principles for recurrent parotid gland tumors.
- To highlight the shift from enucleation to lateral lobectomy in improving outcomes.
Main Methods:
- Review of existing literature on parotid gland tumor management.
- Analysis of recurrence rates associated with different surgical techniques.
Main Results:
- Abandonment of enucleation and adoption of lateral lobectomy have reduced recurrence rates.
- Benign mixed tumors, accounting for 65% of parotid tumors, have recurrence rates between 0.5% and 10%.
Conclusions:
- Effective management of parotid gland tumors requires tailored surgical approaches.
- Surgical options include reexcision, total parotidectomy with facial nerve preservation, and radical parotidectomy with nerve grafting.